Don't Let Joint Pain Hold You Back

Adventist Health Simi Valley is Ventura County’s first Robotic Center of Excellence and provides the community with the latest joint-replacement techniques resulting in less pain, shorter hospital stays and quicker recoveries. - July 02, 2022 - Adventist Health

NF Sports Releases New "Immune Defense(TM)" Drink Mix

Nutrition Supplement Company Aims to Combat Weakened Immune Systems by Helping to Limit the Spread of Viruses at the Cellular Level. - June 30, 2022 - NF Sports

PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator

PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator

PharmStars, the pharma-focused accelerator for digital health startups, announces it is now accepting applications for its Fall 2022 cohort with the theme, “Innovations in Real-World Evidence.” - June 15, 2022 - PharmStars

Defined Bioscience Announces Formation of Scientific Advisory Board

Defined Bioscience, a life science tools company pioneering the development of next generation ingredients for cell culture, today announced the formation of its scientific advisory board (SAB). The SAB is comprised of a distinguished group of academic and industry experts who will advise the... - June 15, 2022 - Defined Bioscience Inc.

GENINVO Launches Its Latest Offering - Innovation as a Service

GENINVO, a leading provider of life science product and business solutions announced the launch of its new, on-demand service: Innovation as a Service. GENINVO has recognized various challenges the pharmaceutical industry faces, especially in the wake of the pandemic. The need to expedite clinical... - June 12, 2022 - GenInvo, Inc.

PharmStars Announces Showcase Pitch Event for Spring 2022 Cohort

PharmStars Announces Showcase Pitch Event for Spring 2022 Cohort

PharmStars, the pharma-focused accelerator for digital health startups, announces the start of its Showcase Event on June 8, 2022. The digital health startups that participated in the 10-week accelerator program will make formal presentations to, and answer questions from, the pharma members of PharmStars. All of PharmStars’ seven members are participating in the Showcase Event. - June 08, 2022 - PharmStars

Period Tracking App, Femometer, Launches Discount and Offers in Celebration of 10 Million Users

Reproductive, period, and pregnancy tracking app, Femometer, is celebrating a milestone of 10 million users. Femometer is offering more than half-off the Prime Membership option, as well as select products purchased through the app. The celebratory discount will be available to users from the 1st of June to 8th of June. - May 31, 2022 - Lollipop Technology Hangzhou Ltd. Co.

Pharmaceutical Compliance Partners Selects Luke Forman, University of Notre Dame, for Summer Internship Program

Pharmaceutical Compliance Partners Selects Luke Forman, University of Notre Dame, for Summer Internship Program

Pharmaceutical Compliance Partners selected Luke Forman, a Science-Business major at University of Notre Dame, as its first summer intern. This is the inaugural year for Pharmaceutical Compliance Partners’ internship program, allowing students to learn about drug development, pharmaceutical compliance, and business operations of life sciences firms. - May 25, 2022 - Pharmaceutical Compliance Partners

Molekule Consulting Announces the Launch of E.U. - Based Operations

Molekule Consulting Announces the Launch of E.U. - Based Operations

Molekule Consulting announces the launch of an E.U. - based business / Molekule Hub continuing their focus on the development of global strategy and advisory services for the biopharmaceutical sector. - May 24, 2022 - Molekule Consulting

Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology

Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology

Global Cancer Technology is developing innovative treatments for deadly diseases like cancer, with a current focus on glioblastoma and breast cancer. To date, Mr. Robert Proulx has held numerous Board positions, is a recognized thought leader in biopharma, and currently holds dual roles as the founder and CEO of Imagion Biosystems. - May 21, 2022 - Global Cancer Technology

LifeBiotic's Botanical Formula Shows Significant Destruction of Multiple GI Cancer Cells

In a new cell model study, the patented LCS101 formula eliminated up to 90% of cancer cells within 72 hours. - May 19, 2022 - Lifebiotic

American Laboratory Products Company Merges with GeneProof

American Laboratory Products Company, Ltd. (“ALPCO”), a specialty in vitro diagnostics company, today announced a merger with GeneProof a.s. (“GeneProof”), a leading molecular diagnostics company based in Brno, Czech Republic. The combination creates a global market leader... - April 21, 2022 - ALPCO

Microvascular Therapeutics Finalizes Facility Certification for the Production of Its Product, MVT-100

Microvascular Therapeutics (MVT), a clinical stage biotechnology company, finalized its manufacturing facility certifications for the GMP production of its first product, MVT-100. - April 21, 2022 - Microvascular Therapeutics, Inc.

River Valley Relief Launches Relief by RVR Line of Marijuana Concentrates

River Valley Relief Launches Relief by RVR Line of Marijuana Concentrates

Arkansas has always been a state known for finding diamonds; just maybe not the kind that are coming out of Fort Smith recently. River Valley Relief Cultivation (“RVR”) has been hard at work producing live diamonds, among other live resin extracts, that were released to many Arkansas... - April 15, 2022 - River Valley Relief

Adventist Health Simi Valley and Moorpark Community College Have Entered Into an Exclusive Multi-Year Partnership

Adventist Health Simi Valley is going directly into the community to provide care outside the walls of the hospital. - April 13, 2022 - Adventist Health

Microvascular Therapeutics Receives Funds from Commercialization Readiness Program for the Development of Its Ultrasound Contrast Agent, MVT-100

MicrovMicrovascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a Commercialization Readiness Program grant from the National Institute of Heart, Lung, and Blood Institute (NHLBI). Wyatt Unger, MD, MBA, Chief Medical Officer of MVT said, “We are... - April 09, 2022 - Microvascular Therapeutics, Inc.

Tavicare Presents Pioneering COVID-19 Monoclonal Antibody IV Therapy for High-Risk Patients in MD

Tavicare Presents Pioneering COVID-19 Monoclonal Antibody IV Therapy for High-Risk Patients in MD

The state of Maryland Health Department has selected the medical facility to provide the antibody therapy IV to affected patients. - April 06, 2022 - Tavicare Inc

Pipelinepharma Marketplace Records Quadruple Growth Over a Single Year

The leading European pharmaceutical marketplace now hosts more than 85 000 CTD dossiers for finished dosage formulation products. Compared to 19 600 products at the start of 2021, the product offering has increased fourfold over a single year. As a response to increasing demand, Pipelinepharma will introduce biosimilar drugs into a separate category. New finished dosage form categories for medical devices and nutraceuticals will also be launched in the coming months. - April 01, 2022 - Pipelinepharma

Female Founded Company Launches New Subscription Box in Portland: The Period Releaf Box™

Female Founded Company Launches New Subscription Box in Portland: The Period Releaf Box™

The Period Releaf Box - a complete set of natural supplements with one goal, conquering your period; Prepare your body for the inevitable before the symptoms begin. - March 23, 2022 - Releaf Box

ALPCO Announced Its Support of the Ukrainian People in a Company-Wide Communication to Its Employees

ALPCO (Salem, NH) announced its support of the Ukrainian people in a company-wide communication to its employees. The message outlined the company's contribution to aid refugees through the American Red Cross and Project Hope in the amount of $5,000 each. Additionally, ALPCO is offering an... - March 16, 2022 - ALPCO

Femometer Donates Medical Equipment to NGOs Across U.S.

Femometer, a division of Lollipop Technology Hangzhou Co. Ltd. donates over 5,000 thermometers to a number of NGOs based in the U.S. to support medical supply shortages caused by the COVID-19 pandemic. The list of NGOs who received donations includes CURE International, Food For The Poor, Famidi... - March 12, 2022 - Lollipop Technology Hangzhou Ltd. Co.

Tavicare Offers Award-Winning Care for Feminine Health Problems

Tavicare Offers Award-Winning Care for Feminine Health Problems

“The 'big picture' approach isn’t just about looking at disease or dysfunction — it’s about looking at a patient in their entirety,” declares Dr. Tavakoli. - March 07, 2022 - Tavicare Inc

Hormonal Treatments by TaviCare is Enabling People to Live Their Life to the Fullest in Chevy Chase, Maryland

Hormonal Treatments by TaviCare is Enabling People to Live Their Life to the Fullest in Chevy Chase, Maryland

Tavicare, a Maryland based medical facility, is helping people with medical conditions through its wide range of medical treatments - March 07, 2022 - Tavicare Inc

Tavicare’s Advanced GAPS Diet Protocol is Helping Patients Get Remarkable Results in as Little as Six Months

Tavicare’s Advanced GAPS Diet Protocol is Helping Patients Get Remarkable Results in as Little as Six Months

Now patients don’t have to wait for years to cure their chronic or urgent health problems with Tavicare’s carefully tailored GAPS protocol. - March 04, 2022 - Tavicare Inc

Johari Digital Expands Its Horizons for Better Healthcare

Johari Digital Healthcare Ltd. is glad to announce that Johari Digital is expanding to Medical Device Park, Jodhpur, Rajasthan, India. With the expansion, Johari Digital will triple its capacity to uptake challenging projects. Johari welcomes projects from startups as well as Global Med-Tech companies. - March 04, 2022 - Johari Digital Healthcare Ltd.

Thrivous Introduces Personalized Medicine Coaching

Thrivous, the human enhancement company, has partnered with Consolidated Health Solutions to provide personalized medicine coaching. Thrivous' mission is to help customers access technology with the greatest potential to improve their brains and bodies. Customers may achieve better results when... - March 03, 2022 - Thrivous

Timothy Healey Joins the Board of Director at Microvascular Therapeutics

Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of Timothy Healey to the MVT Board of Directors. Mr. Healey bring a global perspective to pharmaceutical launch and commercialization. “I am very pleased and honored... - February 23, 2022 - Microvascular Therapeutics, Inc.

Cooperative Buying to Help Launch New Medicines in Small Markets

Large manufacturer minimum order quantities put specialist medicines out of reach of buyers in smaller markets. By grouping pharmaceutical orders from different buyers into a single collective bulk order, Pipelinepharma will help buyers to reach the minimum order quota. The initiative further builds upon Pipelinepharma’s mission to provide better access to medicines for patients all around the world. - February 17, 2022 - Pipelinepharma

Dr. Casey G. Batten, MD is New Medical Director of the Adventist Health Simi Valley Athletic Training Program

Adventist Health Simi Valley adds Team Physician for the Los Angeles Rams as its Medical Director of its Athletic Training Program. - February 11, 2022 - Adventist Health

ImaRx Investments Receives ISO-7 Certification for Its GMP Manufacturing Suite: Both Microvascular Therapeutics and NuvOx Pharma Will Benefit

ImaRx Investments, LLC, an investment firm based in Tucson, Arizona, has received ISO-7 certification on February 1st for its GMP manufacturing suite. The 1,800 square foot, ISO-5 capable clean room is designed for manufacturing injectable drugs. The facility is the only one of its kind in Southern... - February 08, 2022 - Microvascular Therapeutics, Inc.

Shiv Kapoor Joins the Board of Directors at Microvascular Therapeutics

Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of Shiv Kapoor to the MVT Board of Directors. Mr. Kapoor will bring extensive experience in corporate strategy and financing from both biotechnology and finance... - February 03, 2022 - Microvascular Therapeutics, Inc.

MacroArray Diagnostics GmbH (MADx) Partners with ALPCO to Offer a Fully Automated Sample-to-Answer Multiplex Allergy Test Solution to the North American Market

ALPCO (Salem, NH), a leading US producer of novel immunoassay testing platforms, recently announced an exclusive distribution partnership with MacroArray Diagnostics GmbH (Vienna, Austria). Together, they offer a comprehensive line of testing solutions for allergies (IgE-based) and food intolerances (IgG-based), from test material to proprietary hardware and software to process and analyze samples. - February 01, 2022 - ALPCO

Decarbitation Inc. Product Launch: New Cannabis Crude Oil Decarboxylation Technology Using Controlled Cavitation

Decarbitation Inc. Product Launch: New Cannabis Crude Oil Decarboxylation Technology Using Controlled Cavitation

DecarbitationTM will be launching its website as well brand new 2 and 25 gallon systems for the decarboxylation of cannabis on February 2, 2022. - February 01, 2022 - Decarbitation Inc.

Aelius LED New Product Line Roots Them Into Horticulture

New Light Recipe Technology is Ideal for the Microgreen Grower. - January 15, 2022 - AeliusLED

Johari Digital Healthcare Inaugurated the "Johari Center of Excellence" in IIT Jodhpur Technology Park

Most research and innovations from Academia end up in publications or are shelved, but now with Industry and academia collaboration it will have chance to get converted into a real product through engineering and transfer to manufacturing cycle along with required regulatory compliances. - January 10, 2022 - Johari Digital Healthcare Ltd.

PharmStars Now Accepting Applications for Spring 2022 Accelerator Program; Startups with Digital Innovations in Neurological Disease Are Welcome to Apply

PharmStars Now Accepting Applications for Spring 2022 Accelerator Program; Startups with Digital Innovations in Neurological Disease Are Welcome to Apply

PharmStars, the pharma-focused accelerator for digital health startups, is now accepting applications for its spring 2022 cohort with the theme, “Digital Innovations in Neurological Disease.” - January 04, 2022 - PharmStars

Viron Announces New CFO Hire

Viron Announces New CFO Hire

Viron Therapeutics Holdings, Inc., a Boston biotech company, is pleased to announce the appointment of Jodie Fisher as its Executive Vice President and Chief Financial Officer (CFO). Fisher will lead the Company’s finance organization and drive investor relations. Fisher’s entry into... - December 29, 2021 - Viron Therapeutics Holdings, Inc.

Pharmaceutical Companies Shift to Near-Shore Medicines Sourcing as Supply Chain Risks Intensify

With global supply chains under stress due to COVID-19 pandemic, European pharmaceutical companies and distributors are increasingly looking for alternative supply channels inside the EU block. - December 16, 2021 - Pipelinepharma

Mirror Biologics, Inc. Announces Close of a $14 Million Financing Round

Mirror Biologics, Inc. Announces Close of a $14 Million Financing Round

This Funding will be Used, in Part, to Launch an Asian Phase II/III Randomized Controlled Registration Trial for Advanced Liver Cancer in Q1/2-2022. - December 09, 2021 - Mirror Biologics, Inc.

PharmStars Announces 2021 Accelerator Graduates

PharmStars Announces 2021 Accelerator Graduates

12 digital health startups have successfully completed PharmStars’ inaugural 10-week pharma-focused accelerator program. - December 08, 2021 - PharmStars

Parvus Therapeutics Announces Development and Manufacturing Agreement with Resilience to Advance Novel Autoimmune Drug Candidate PVT201

Parvus Therapeutics, a biopharmaceutical company developing Navacim™ platform-based disease-specific immunoregulator therapeutics to treat autoimmune diseases by activating endogenous generation of disease-specific regulatory T cells (Tregs) without impairing normal immune system function,... - November 29, 2021 - Parvus Therapeutics U.S., Inc.

Intuitive Healer, Dr. Mom, Publishes Book Inspired by Granddaughter

Recent release, "It's a Beautiful Night" from Covenant Books author, Deborah Kitt, is a dazzling short read that teaches children to appreciate the mesmerizing beauty of the night, for God's everlasting love for us shines even in the darkness. Kitt is an intuitive healer. Her new book, "It's a Beautiful Night," was inspired by the birth of her first granddaughter, Corinne, who lives in Japan. The book brings an energy of love and healing to all who read and listen to the accompanying song. - November 20, 2021 - Dr. Mom

Parvus Therapeutics and Ardena Enter Agreement for Tech Transfer, Scale-Up and GMP Manufacturing of Navacim Nanoparticles

Today Parvus announced it has entered into an agreement with Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO), for process development, scale-up and GMP manufacturing of NavacimTM nanoparticles, a key building block for all of our Navacim platform drug development candidates. - November 19, 2021 - Parvus Therapeutics U.S., Inc.

Careington® CFO Melissa Baumann Honored as a Dallas Business Journal 2021 CFO of the Year Award Winner

Careington International Corporation is excited to announce Melissa Baumann has been honored as a CFO of the Year Award winner by the Dallas Business Journal. This is the Dallas Business Journal’s 13th annual CFO of the Year Awards which honors distinguished North Texas CFOs who demonstrate... - November 18, 2021 - Careington

GENINVO Launches Centre of Excellence for Data Science and Analytics to Help Clients Unlock Insights Using Data Science

GENINVO, a leading provider of life sciences product and business solutions organization, announced the launch of a Centre of Excellence for Data Science and Analytics (DSA CoE). The DSA is a resolute team of experts comprising of life science and technology domains. Data Science and Analytics CoE... - November 18, 2021 - GenInvo, Inc.

PharmStars Announces Showcase Event for Inaugural Class

PharmStars Announces Showcase Event for Inaugural Class

PharmStars, a pharma-focused accelerator for digital health startups, announces the start of its 2021 Showcase Event. At the Showcase Event, the 12 startups in the accelerator’s current cohort will pitch their digital health solutions to PharmStars’ pharma members. The startups and pharma members will also have the opportunity to meet privately to discuss potential partnership opportunities. - November 17, 2021 - PharmStars

Mirror Biologics Announces Issuance of US Patent Covering Next Generation Therapeutic Vaccine Technology for Treatment of Cancer and Infectious Disease

Mirror Biologics Announces Issuance of US Patent Covering Next Generation Therapeutic Vaccine Technology for Treatment of Cancer and Infectious Disease

Mirror Biologics, Inc., a private clinical stage biopharmaceutical company, today announces the issuance of US Patent No. 11,160,852, “Method of Vaccinating Using Allogeneic Cells,” covering methods for creating a next generation of therapeutic vaccines against cancers and infectious... - November 17, 2021 - Mirror Biologics, Inc.

South-Tek Systems Appoints Jens Bolleyer as CEO

South-Tek Systems Appoints Jens Bolleyer as CEO

South-Tek Systems announces Jens Bolleyer was appointed as the company’s CEO effective August 30, 2021. An experienced business leader, Mr. Bolleyer steps into the CEO role at South-Tek with significant experience in manufacturing businesses serving commercial & industrial plumbing and... - November 16, 2021 - South Tek Systems

Careington® Works with Great Speech to Add Virtual Speech Therapy Services to Its Telehealth Offerings Nationwide

Careington International Corporation, a leader in the non-insured health care benefits space, is pleased to begin working with Great Speech Inc., a pioneer in the virtual speech therapy space, adding virtual speech therapy to Careington’s ever-expanding telehealth offerings. This relationship... - November 11, 2021 - Careington

Genetically Steady and Cost-Effective Gene Knockout Stable Cell Lines Products at Creative Biogene

Creative Biogene creatively develops a series of genetically steady and cost-effective gene knockout stable cell lines products for domestic and overseas clients. - November 06, 2021 - Creative Biogene

Press Releases 201 - 250 of 3,160